Literature DB >> 9714715

Cholesterol affects African swine fever virus infection.

C Bernardes1, A António, M C Pedroso de Lima, M L Valdeira.   

Abstract

African swine fever virus (ASFV) enters cells by receptor mediated endocytosis and requires a fusion event between the viral envelope and the limiting membrane of the endosome at low pH. In order to investigate the role of cholesterol in the early stages of ASFV infection, we have studied the effect of the removal of cell and viral membrane cholesterol by cholesterol oxidase treatment of cells and virions, as well as the effect of some inhibitors of cholesterol synthesis on the infectious pathway. In addition, we have investigated viral infection in cholesterol-depleted Vero cells. Both cholesterol-depleted and cholesterol oxidase-treated Vero cells were unaltered in their ability to bind or internalize the virus, but were blocked in ASFV fusion and subsequent virus replication. Our results indicate that ASFV infection is affected by cholesterol in the target membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714715     DOI: 10.1016/s0005-2760(98)00051-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin.

Authors:  Hetal K Patel; David C Willhite; Rakhi M Patel; Dan Ye; Christopher L Williams; Eric M Torres; Kent B Marty; Robert A MacDonald; Steven R Blanke
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 2.  Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.

Authors:  Diky Mudhakir; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

3.  Biochemical consequences of a mutation that controls the cholesterol dependence of Semliki Forest virus fusion.

Authors:  P K Chatterjee; M Vashishtha; M Kielian
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Small rho GTPases and cholesterol biosynthetic pathway intermediates in African swine fever virus infection.

Authors:  Jose I Quetglas; Bruno Hernáez; Inmaculada Galindo; Raquel Muñoz-Moreno; Miguel A Cuesta-Geijo; Covadonga Alonso
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  Dynamin- and clathrin-dependent endocytosis in African swine fever virus entry.

Authors:  Bruno Hernaez; Covadonga Alonso
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

6.  African swine fever virus uses macropinocytosis to enter host cells.

Authors:  Elena G Sánchez; Ana Quintas; Daniel Pérez-Núñez; Marisa Nogal; Susana Barroso; Ángel L Carrascosa; Yolanda Revilla
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

7.  Phenotyping and susceptibility of established porcine cells lines to African Swine Fever Virus infection and viral production.

Authors:  Elena G Sánchez; Elena Riera; Marisa Nogal; Carmina Gallardo; Paloma Fernández; Raquel Bello-Morales; José Antonio López-Guerrero; Carol G Chitko-McKown; Jürgen A Richt; Yolanda Revilla
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 8.  An Update on African Swine Fever Virology.

Authors:  Axel Karger; Daniel Pérez-Núñez; Jesús Urquiza; Patricia Hinojar; Covadonga Alonso; Ferdinando B Freitas; Yolanda Revilla; Marie-Frédérique Le Potier; Maria Montoya
Journal:  Viruses       Date:  2019-09-17       Impact factor: 5.048

9.  Phytochemical analysis and in-vitro anti-African swine fever virus activity of extracts and fractions of Ancistrocladus uncinatus, Hutch and Dalziel (Ancistrocladaceae).

Authors:  Folorunso O Fasina; Oyinlola O Olaokun; Olusola O Oladipo; Margaret M Fasina; Adesoji A Makinde; Livio Heath; Armanda D S Bastos
Journal:  BMC Vet Res       Date:  2013-06-19       Impact factor: 2.741

Review 10.  Mechanisms of Entry and Endosomal Pathway of African Swine Fever Virus.

Authors:  Elena G. Sánchez; Daniel Pérez-Núñez; Yolanda Revilla
Journal:  Vaccines (Basel)       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.